Gsk (GSK) Dividends Paid - Common (QoQ) (2009 - 2026)

Gsk (GSK) Dividends Paid - Common (QoQ) (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -66.68%
Dec 31, 2025 -289.33%
Sep 30, 2025 17.92%
Jun 30, 2025 78.89%
Mar 31, 2025 -369.18%
Dec 31, 2024 -58.05%
Sep 30, 2024 25.81%
Jun 30, 2024 80.55%
Mar 31, 2024 -644.26%
Dec 31, 2023 -34.08%
Sep 30, 2023 57.88%
Jun 30, 2023 74.59%
Mar 31, 2023 -111.16%
Dec 31, 2022 2,507.71%
Mar 31, 2022 -296.50%
Dec 31, 2021 -103.22%
Sep 30, 2021 -35.03%
Jun 30, 2021 91.00%
Mar 31, 2021 18.22%
Dec 31, 2020 39.57%